Search
for
Sort by
Research 751–780 of 1000+
- Androgenetic alopecia treated with topical minoxidil
- Regeneration of Chronic Wounds with Allogeneic Platelet Gel versus Hydrogel Treatment: a Prospective Study
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- 5α-reductase inhibitors/finasteride
- Treatment of Keratosis Pilaris With 810-nm Diode Laser
- Safety and efficacy analysis of liposomal insulin-like growth factor-1 in a fluid gel formulation for hair-loss treatment in a hamster model
- Topical Calcipotriol for Preventive Treatment of Hypertrophic Scars
- Topical minoxidil for extended areate alopecia
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Locally Delivered Umbilical Cord Mesenchymal Stromal Cells Reduce Chronic Inflammation in Long-Term Nonhealing Wounds: A Randomized Study
- Transdermal viprostol in the treatment of male pattern baldness
- The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment
- Therapeutic potential of hair follicle-derived stem cell intranasal transplantation in a rat model of ischemic stroke
- The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism
- Platelet-Rich Plasma Therapy for Male and Female Pattern Hair Loss
- Efficacy and Safety of a Topical Botanical in Female Androgenetic Alopecia: A Randomized, Single-Blinded, Vehicle-Controlled Study
- A randomized clinical trial on therapeutic effects of 0.25 mg oral minoxidil tablets on treatment of female pattern hair loss
- Treatment of contact burn injury with hypericum perforatum: An experimental study
- The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects
- Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- The effects of garlic topical gel (5%) in the treatment of alopecia areata
- Medikamentöse Therapie der BPH Ist eine Kombinationstherapie mit 5α-Reduktasehemmern und α-Rezeptorenblockern sinnvoll?
- Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): Results from the first 12 weeks of PIONEER II
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- Statins for women with polycystic ovary syndrome not actively trying to conceive
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review